Status:

COMPLETED

Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia

Lead Sponsor:

Seoul National University Hospital

Conditions:

Schizophrenia

Eligibility:

All Genders

20-55 years

Brief Summary

The purpose of this study is to evaluate abnormal dopamine synthesis and connectivity according to the antipsychotic treatment response in schizophrenia.

Eligibility Criteria

Inclusion

  • diagnosis of schizophrenia
  • clinically stable state

Exclusion

  • history of previous head injury, epileptic disorder, other medical comorbidity
  • substance abuse/dependence

Key Trial Info

Start Date :

May 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2016

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT02248987

Start Date

May 1 2014

End Date

May 1 2016

Last Update

April 8 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea